ViiV – MPP, Dolutegravir License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingViiV – MPP, Dolutegravir License Agreement

BMS – MPP, Hepatitis C Antiviral (daclatasvir – DAC) License & Tech Transfer Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingBMS – MPP, Hepatitis C Antiviral (daclatasvir – DAC) License & Tech Transfer Agreement

AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingAbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) License Agreement

University of Liverpool – MPP, HIV Therapeutic Collaboration Agreement and Patent & Know-How License

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingUniversity of Liverpool – MPP, HIV Therapeutic Collaboration Agreement and Patent & Know-How License

AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingAbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement

Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

WHO Template Material Transfer Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingWHO Template Material Transfer Agreement

UK Lambert Toolkit, Model Consortium Agreement D

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingUK Lambert Toolkit, Model Consortium Agreement D

IMI 2 Model Grant Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingIMI 2 Model Grant Agreement